Accuray Inc. has made significant strides in its financial strategy by issuing Series A Convertible Preferred Stock and implementing a reverse stock split. These actions are part of a broader effort to strengthen its capital structure and attract new investments.

On November 13, 2026, the company announced the completion of these initiatives through a filing with the Securities and Exchange Commission, detailing the issuance of 55,000 shares of Series A Preferred Stock for a total of $55 million. This includes $15 million in cash and the conversion of $40 million in existing debt.

Background

Accuray Inc. is a company that specializes in surgical and medical instruments and apparatus, classified under the SIC code 3841. It trades on the Nasdaq under the ticker ARAY. The company has been active in the market, with several recent filings, including a 10-Q on November 6, 2026, and multiple 8-K reports detailing various corporate actions.

What the Filing Says

According to the SEC filing (accession number 0001437749-26-036943), the Series A Preferred Stock was issued in a private placement to accredited investors. The filing states, "The Series A Preferred Stock ranks senior to the Company’s common stock with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation." This indicates a strategic move to secure funding while providing favorable terms to investors.

Impact

This restructuring may have significant implications for Accuray's operations and its competitive positioning within the surgical and medical instruments industry. The issuance of preferred stock could provide the company with the necessary capital to enhance its product offerings and expand its market reach. Additionally, the reverse stock split, executed at a 1-for-40 ratio, is expected to consolidate shares, potentially improving the stock's market perception.

What's Next

The filing does not specify what happens next, but the company is likely to focus on leveraging this new capital to drive growth and innovation in its product lines. Investors and stakeholders will be watching closely to see how Accuray utilizes these changes to enhance its market position.